Could a simple blood test and scan replace painful bone marrow biopsies for myelofibrosis patients?
NCT ID NCT07419178
First seen Feb 21, 2026 · Last updated May 13, 2026 · Updated 13 times
Summary
This study is testing a new method to detect and track bone marrow scarring (fibrosis) in people with myelofibrosis without needing a painful bone marrow biopsy. Researchers will use a blood test and a special PET scan tracer that targets a protein called CCR2, which is linked to fibrosis. The goal is to see if these non-invasive tests can accurately identify the fibrotic stage of the disease, making monitoring easier and more comfortable for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSIS (MF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dipartimento di Medicina e Chirurgia
RECRUITINGParma, Italy, 43126, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.